# Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

> **NCT00285389** · PHASE2 · COMPLETED · sponsor: **French Innovative Leukemia Organisation** · enrollment: 39 (actual)

## Conditions studied

- Mantle Cell Lymphoma

## Interventions

- **DRUG:** Adriblastin
- **DRUG:** dexamethasone
- **DRUG:** Chlorambucil
- **DRUG:** rituximab
- **DRUG:** cyclophosphamide
- **DRUG:** alkeran
- **PROCEDURE:** Total body irradiation (8Gy/4fr)
- **DRUG:** vincristine

## Key facts

- **NCT ID:** NCT00285389
- **Lead sponsor:** French Innovative Leukemia Organisation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2005-12
- **Final completion:** 2008-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00285389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00285389, "Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00285389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*